ArticleThe Journal of antibiotics2019

New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.

Zsolt Szűcs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.